Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells

Table 1 Cisplatin sensitivity and NER capacity of human ovarian cancer cell lines.

¹IC50 was determined after 1 h treatment with increasing concentrations of cisplatin. Cell survival was determined by methylene blue staining as described in the Methods.
²NER capacity was assessed by determining the removal rate of DNA lesions in cells following various culture times.

ISSN: 1476-4598